Self-administered questionnaires are commonly used to measure exposures and outcomes in epidemiological research and thus need good validity. With increasing numbers of cancer survivors, there is interest in the ongoing assessment of therapy-related complications. A medical record validation of patient-reported complications following bone marrow transplantation (BMT) was performed using a self-administered questionnaire. The study population consisted of 100 patients who had undergone BMT at the City of Hope. The following selfreported complications were validated using medical records: ocular, endocrine, cardiovascular, musculoskeletal, pulmonary, gastrointestinal, neurological, graft-versus-host disease, and subsequent cancers. Using information from medical records as the standard, sensitivities ranged from 52.9% for subsequent cancers to 100% for avascular necrosis and hypothyroidism. Specificities ranged from 75.4% for ocular complications to 100% for avascular necrosis. naires for reporting of health-related conditions rather than clinical examinations, biochemical measurements, review of medical records, and structured interviews. Therefore, appropriate studies need to be conducted to ensure that data collection instruments can provide valid and reliable measures of exposures and outcomes. There are reports in the literature assessing the validity of self-reported illnesses with most studies finding 80-90% of self-reported conditions confirmed by medical records.
naires for reporting of health-related conditions rather than clinical examinations, biochemical measurements, review of medical records, and structured interviews. Therefore, appropriate studies need to be conducted to ensure that data collection instruments can provide valid and reliable measures of exposures and outcomes. There are reports in the literature assessing the validity of self-reported illnesses with most studies finding 80-90% of self-reported conditions confirmed by medical records. [1] [2] [3] [4] [5] [6] [7] With improved therapeutic strategies the number of cancer survivors in the general population is continually increasing. 8 Many therapeutic regimens consist of combinations of radiation and/or chemotherapy, including bone marrow transplantation (BMT), which have been associated with both acute and long-term complications. 9, 10 Frequently, cancer survivors treated at regional centers live in a wide geographic area and may not return to the treatment center for extended follow-up. Thus, for research purposes, it is often necessary to rely upon self-reported health status.
We conducted a medical record validation of patientreported information regarding long-term complications, such as cardiopulmonary dysfunction, endocrine dysfunction, and subsequent cancers following BMT. We present the assessment of validity and reliability of primary outcomes of interest.
Materials and methods

Patient population
To be eligible for this validation study, patients were required to have undergone BMT between 1 January 1974 and 31 December 1997 at the City of Hope National Medical Center (COH), survived at least 2 years from the date of transplant without evidence of persistent or recurrent cancer, and to be English speaking. We selected our sample from the entire cohort of 3676 patients who had undergone a BMT between 1976 and 1997. Two hundred and twelve study subjects were randomly selected by their date of transplant, stratified into the following categories: stratum 1: date of transplant between 1976 and 1985; stratum 2: date of transplant between 1986 and 1990; stratum 3: date of transplant between 1991 and 1997. The agreement between self-reported complications in the questionnaire and data from medical records was assessed for the first 100 respondents.
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This study was approved by the Institutional Review Board for the Protection of Human Subjects at the City of Hope National Medical Center. A cover letter explaining the study was mailed to the patients, along with the consent form and the questionnaire. The subjects were encouraged to call the investigators with any questions before signing the consent form. The consent was signed and returned along with the completed questionnaire by the participating subjects. The participants received no incentives for completing the questionnaire and were only contacted to ask if they had received the questionnaire, to fill out sections that were inadvertently left blank, or to clarify any inconsistencies in the responses.
Bone marrow transplant survivor questionnaire
The Bone Marrow Transplant Survivor Study (BMTSS) questionnaire used in this study was a 255-item instrument adapted from the questionnaire used in the Childhood Cancer Survivor Study to include items specifically related to the BMT population. The questionnaire examined a variety of topics including demographics, access to and use of medical care, and post-BMT complications (hearing, vision, speech, endocrine, central nervous, cardiopulmonary system, gastrointestinal, genitourinary systems, graft-versus-host disease, and psychological dysfunction). The questionnaire also included a detailed family history, reproductive history, health habits, physical activity, and sociodemographic factors such as education, marital status, employment, and insurance. Responses to medical conditions primarily consisted of 'yes/no/not sure' and the age of first occurrence in response to questions prefaced with the following: 'Have you ever been told by a doctor or other health care professional that you have, or have had?' or 'Please indicate if you have ever had any of the following surgical procedures done.'
Validation of post-BMT complications
Complications were recorded under one of the following nine broad categories: musculoskeletal disorders, cardiovascular compromise, ocular complications, endocrine dysfunction, neurological complications, gastrointestinal complications, graft-versus-host disease (GVHD), pulmonary compromise, and subsequent cancers. Within each broad disease category, we examined a set of selected complications: under musculoskeletal disorders, we examined avascular necrosis, osteoporosis, arthritis, and arthralgias; under cardiovascular compromise, we studied hypertension, myocardial infarction, pericarditis, congestive heart failure, and chest pain or shortness of breath; under ocular complications, we examined cataracts, xerophthalmia, double vision, glaucoma, floaters, detached retina, and vision correction; under endocrine dysfunction, we examined hypothyroidism, hyperthyroidism, hypogonadism, diabetes, growth hormone deficiency, and hyperlipidemia; under neurological complications we studied epilepsy, paralysis of any kind, migraines, problems with balance or equilibrium, decreased sense of touch, neuropathy, and prolonged pain in arms, legs or back; under gastrointestinal complications, we examined gallstones, cirrhosis of the liver, jaundice, ulcers, disease of the esophagus, and chronic diarrhea; under graft-versus-host disease, we studied acute and chronic GVHD, both limited and extensive involving the skin, liver or intestines; under pulmonary compromise, we studied bronchitis, asthma, pleurisy, chronic cough, need for extra oxygen, lung fibrosis, emphysema, and pneumonia.
For purposes of validity, medical records were used as the 'gold standard'. The entire medical record was reviewed and information abstracted for all post-BMT complications. If a condition was mentioned in the medical record, it was assigned a 'yes' value, otherwise it was assigned a 'no' value. Similarly, each response in the BMTSS questionnaire was recorded as a 'yes' value for a positive response and a 'no' value for a negative response in the corresponding disease categories. Certain questions within the BMTSS questionnaire served as internal validators -for example, if patients reported having used thyroid replacement hormone or received hormone replacement therapy for hypogonadism, this would trigger a 'yes' response under the 'endocrine complications' category. Similarly, if the patient had reported having undergone coronary bypass surgery, this would indicate that the patient should respond with a 'yes' for the cardiac complications. Clinical data was abstracted from the medical records at the COH for the large majority of the complications -however for some clinical data, such as clinical work-up for infertility or management of myocardial infarction outside COH, data from outside facilities was reviewed and incorporated into the study.
Validity and reliability
Sensitivity and specificity validity measures of the questionnaire were calculated for binomial categorical variables. The term 'sensitivity' is defined as the proportion of those with the complication (as defined by the medical records) who are correctly classified by the questionnaire. 'Specificity' is the proportion of the study population that truly does not have the complication and is correctly classified by the questionnaire. 11 Further validation statistics included positive predictive value (PPV), defined as the proportion of true positives correctly identified by the questionnaire, and negative predictive value (NPV), defined as proportion of true negatives correctly identified by the questionnaire.
Reliability measures of percent agreement and kappa were also calculated. 12 The kappa statistic measures the extent of exact agreement, adjusting for chance agreement. Landis and Koch 13 suggest that a kappa greater that 0.75 represents excellent agreement beyond chance, between 0.40 to 0.75 represents intermediate agreement beyond chance, and below 0.40 represents poor agreement beyond chance. All data analysis was conducted using Epilog software.
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Results
Medical records were obtained and data abstracted for all 100 patients. Sixty-one patients had received an allogeneic BMT, while 39 received an autologous BMT. Patient characteristics are shown in Table 1 along with a comparison between the 100 patients that were included in the study, and the remaining 112 of the original cohort of 212 that were not. With the exception of ethnic differences, there were no significant differences between the two groups in terms of gender, primary diagnoses, age at transplant, or time since transplant.
The results of validation and reliability are presented in Table 2 . Within broad categories high sensitivities, specificities, PPV, NPV, and kappa values were found for musculoskeletal disorders, cardiovascular complications, endocrine dysfunction, gastrointestinal complications, pulmonary complications and graft-versus-host disease. Low validity and reliability values were found for ocular complications, neurological disorders, and subsequent cancers.
Within specific categories, high validation values were found for avascular necrosis, osteoporosis, hypothyroidism, and hypogonadism. Meanwhile, moderate validity and reliability values were found for hypertension, myocardial infarction, cataracts, xerophthalmia, and subsequent cancers excluding skin cancers.
The subsequent cancers reported included cervical cancer, basal cell carcinoma, and soft tissue sarcoma. The sensitivity and PPV for subsequent cancers reported by BMT survivors were low. However the specificity and NPV were high, with an intermediate level of agreement. Sensitivity was 100% if skin cancers were excluded from the analysis.
We further examined the influence of demographic vari- Including lymphoblastic lymphoma/leukemia, acute undifferentiated leukemia, multiple myeloma, acute promyelocytic leukemia, chronic lymphocytic leukemia.
Bone Marrow Transplantation ables such as gender, ethnicity, annual household income (48% had an annual household income greater than $60 000), education (42% had a college degree), age at BMT, and length of follow-up from BMT on the validity and reliability of the reported complications. However, no meaningful differences were identified (data not shown).
Discussion
Self-reported data are commonly used in epidemiological and clinical research studies as the sole or primary source of exposure and outcome information. 15 Through this approach, investigators can collect information that may not be available from other sources or may require gathering data from multiple sources and thus decrease the likelihood of complete ascertainment. Since it is often not possible to perform physical examinations or abstract data for all patients within many retrospective cohorts of BMT survivors, we tested the accuracy of self-reported complications. Our results indicate a good overall agreement between self-report and medical records for post-BMT complications, which are in agreement with the reports in the literature for a variety of medical conditions. [1] [2] [3] [4] [5] [6] [7] For every major disease category, with the exception of subsequent cancers, the ability of the questionnaire to correctly identify the complication was 80% or greater. For ocular complications, endocrine dysfunction, gastrointes- Table 2 Validity and reliability of self-reported long-term complications among cancer survivors tinal system, and pulmonary system, the sensitivity was greater than 90% indicating that the questionnaire is a good instrument to identify those who truly have these complications. Many results improved when specific, rather than broad, complications were studied. The sensitivity increased for avascular necrosis (100%), hypothyroidism (100%), hypogonadism (96.1%), and xerophthalmia (93.3%). Although the sensitivity of subsequent cancers was the lowest at 52.9%, it increased to 100% when skin cancers were excluded from the analysis. Skin cancers were probably not reported by the BMT survivors, because treatment often consists of a simple excision, with no chemotherapy or radiation therapy to follow. These results are consistent with Bergmann et al 6 who showed a low sensitivity for melanoma. On the other hand, Colditz et al 5 reported a 91% rate of patients correctly reporting the removal of a skin cancer in the Nurses Health Study. Nurses, however, would be more likely to recall medical conditions or procedures than the average non-medical patient would.
The specificity for each major disease category exceeded 80%, with the exception of ocular and neurological complications. Low specificities in these two areas indicate complications that either have a fluctuating course, such as neurological complications, or have ill-defined diagnostic criteria, such as certain ocular complications (ie blurred or double vision). These findings have been previously documented. 1 Specificities for musculoskeletal disorders, cardiovascular compromise, gastrointestinal complications, GVHD, pulmonary compromise, and second cancers were over 90% which indicates that the questionnaire has a good ability to correctly identify those who do not have a complication. When distinct categories were analyzed, both validity and reliability improved.
The PPV was highest for the major disease categories such as musculoskeletal disorders, cardiovascular compromise, endocrine dysfunction, gastrointestinal complications, and GVHD and were above 85%. The results indicate that use of self-report accurately classifies patients with these complications. Low PPV was found for xerophthalmia and subsequent cancers. Patients often reported xerophthalmia with no corroboration in the medical records which suggests that patients may experience mild symptoms that might not be addressed by the physician during a routine visit, and hence are not recorded in the chart. For subsequent cancers, misreporting of recurrence or relapse of the original disease decreased the PPV for that complication, as two of the three false positives were relapses. The NPV was above 85% for all of the major categories and specific complications with the exception of the central nervous system. All of these values were generally high and indicate that the questionnaire has a good ability to predict that the patients do not have the complication.
Neurological and ocular complications were found to have the highest false positive rates while very low false positives rates existed for avascular necrosis, osteoporosis, myocardial infarction, and hypogonadism. These latter complications are associated with a considerable level of morbidity, both physical and emotional, often restricting a patient's activities (avascular necrosis, myocardial infarction), or necessitating daily intake of medications (hypogonadism), and are therefore more likely to be accurately classified by the patients. Our false positive results are better than previous studies concerning myocardial infarction. Paganini-Hill and Chao 3 found a 40% false positive rate and Colditz et al 5 indicated only a 68% agreement between medical records and patients' responses.
Very low false negatives were reported for specific complications, such as avascular necrosis and hypothyroidism and again the discrete complication categories are a more exact indicator of a true dysfunction. Among the specific complications evaluated, hypertension had a high false negative rate, which we speculate is a result of the fluctuating course of secondary hypertension.
The GVHD is a specific complication following BMT and the sensitivity, specificity, and kappa were all high in our study. The six subjects that did not report GVHD, but had GVHD recorded in their medical record (false negatives) were reviewed in detail. Four of the six patients had GVHD of the liver alone, one had liver and skin involvement, and one patient had GVHD of the skin alone. Definitive diagnosis of GVHD of the liver requires a liver biopsy, and in most situations, the latter is avoided, and patients are treated empirically for GVHD of the liver. Thus, because of rather 'soft' criteria used to diagnose this condition, GVHD of the liver may be difficult for the patient to remember, accounting for the false negatives. Furthermore, the PPV for GVHD indicated that 97.6% of the patients who reported GVHD actually had the disease.
This validation study has a number of strengths. First, the patient population studied is unique because of the intensity of treatment received and the increased risk of a wide variety of complications. Second, this singleinstitution study allows the investigators easy access to medical records and detailed descriptions of the complications due to the large majority of patients visiting the COH exclusively, which likely results in thorough and complete documentation, and hence abstraction of data.
However, several limitations to our report need to be discussed. First, the medical records were assumed to be complete and correct in order to serve as the 'gold standard', which is an assumption that may not be correct. 16 Incomplete or inaccurate medical record information could account for much of the discrepancy between the self-report and the medical records, casting unwarranted doubt on the self-report. It might be possible that the physician neglected to notice or record the condition, even though it was indeed present. This might be true in the present study with some of the patients reporting xerophthalmia and neuropathies.
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Second, the general excellent agreement observed is based upon a sample consisting of the first 100 respondents from among the randomly selected sample of 212. If BMT survivors who promptly responded to the questionnaire are more likely to accurately report outcomes identified in their medical record, then our results may be better than in the overall population. However, with the exception of ethnicity, a comparison between the two populations did not reveal any significant differences in their sociodemographic characteristics. At the time of article submission, information regarding the socio-economic status was available for 51 of the remaining 112 patients not included in the validation study (the remaining 61 had not yet completed the questionnaire). We compared the selfreported education and annual household income between 100 study respondents and the 51 additional patients and found that the educational level was not significantly different between the two groups. However the first 100 participants seemed to have a higher annual household income level.
These results showed that the agreement between selfreported data and medical records was good for well-known complications that have clear diagnostic criteria and are easily communicated to the patient. Overall these results are very encouraging and indicate that the ability of cancer survivors to report a complication accurately is quite high.
